Management of Subarachnoid Hemorrhage with Intraventricular Hemorrhage

Immediate Stabilization and Transfer

The American Heart Association recommends transfer to a high-volume center with neurocritical care capabilities and experienced cerebrovascular surgeons for patients with subarachnoid hemorrhage and intraventricular hemorrhage, as this is associated with lower mortality and better functional outcomes 1, 3, 4
Care should be provided in a dedicated neurocritical care unit by a multidisciplinary team using evidence-based protocols, according to the American Heart Association 1, 5

Urgent cerebrospinal fluid diversion is the cornerstone of managing intraventricular hemorrhage with subarachnoid hemorrhage, and external ventricular drainage should be placed urgently for acute symptomatic hydrocephalus associated with intraventricular hemorrhage, as recommended by the American Heart Association 2, 5, 6

Evaluation by both endovascular and neurosurgical specialists is necessary to determine the optimal treatment approach for aneurysm securing, according to the American Heart Association 5
Aneurysm securing should be performed as early as feasible to reduce rebleeding risk, which is particularly critical given the presence of an external ventricular drain, as recommended by the American Heart Association 2, 5

The American Heart Association recommends oral nimodipine 60 mg every 4 hours for 21 consecutive days to improve neurological outcomes in patients with subarachnoid hemorrhage and intraventricular hemorrhage 2, 5
Maintenance of euvolemia with close monitoring and goal-directed treatment of volume status is recommended to improve outcomes in patients with subarachnoid hemorrhage and intraventricular hemorrhage, according to the American Heart Association 7, 8, 5

Prophylactic hemodynamic augmentation should be avoided in patients at risk for delayed cerebral ischemia, and induced hypertension is recommended for symptomatic delayed cerebral ischemia unless baseline blood pressure is elevated or cardiac status precludes it, as recommended by the American Heart Association 2, 5

Frequent neurological assessments and vital sign monitoring with validated dysphagia screening protocols should be implemented in patients with subarachnoid hemorrhage and intraventricular hemorrhage, according to the American Heart Association 5
Immediate post-treatment cerebrovascular imaging is recommended to identify aneurysm remnants or recurrence, and delayed follow-up vascular imaging should be performed with consideration for retreatment if clinically significant remnants are identified, as recommended by the American Heart Association 2, 5